Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months.

Pennesi ME, Birch DG, Jayasundera KT, Parker M, Tan O, Gurses-Ozden R, Reichley C, Beasley KN, Yang P, Weleber RG, Bennett LD, Heckenlively JR, Kothapalli K, Chulay JD, For The Xlrs-Study Group.

Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5941-5956. doi: 10.1167/iovs.18-24565.

2.

ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion.

Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Ă–zmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS.

Retina. 2018 Nov 20. doi: 10.1097/IAE.0000000000002394. [Epub ahead of print]

PMID:
30475288
3.

T Helper 1 Cellular Immunity Toward Recoverin Is Enhanced in Patients With Active Autoimmune Retinopathy.

Lundy SK, Nikoopour E, Karoukis AJ, Ohara R, Othman MI, Tagett R, Jayasundera KT, Heckenlively JR.

Front Med (Lausanne). 2018 Sep 13;5:249. doi: 10.3389/fmed.2018.00249. eCollection 2018.

4.

Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study.

Gregori NZ, Callaway NF, Hoeppner C, Yuan A, Rachitskaya A, Feuer W, Ameri H, Arevalo JF, Augustin AJ, Birch DG, Dagnelie G, Grisanti S, Davis JL, Hahn P, Handa JT, Ho AC, Huang SS, Humayun MS, Iezzi R Jr, Jayasundera KT, Kokame GT, Lam BL, Lim JI, Mandava N, Montezuma SR, Olmos de Koo L, Szurman P, Vajzovic L, Wiedemann P, Weiland J, Yan J, Zacks DN.

Am J Ophthalmol. 2018 Sep;193:87-99. doi: 10.1016/j.ajo.2018.06.012. Epub 2018 Jun 27.

PMID:
29940167
5.

Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.

Abramoff MD, Fort PE, Han IC, Jayasundera KT, Sohn EH, Gardner TW.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):519-527. doi: 10.1167/iovs.17-21873.

6.

Double hyperautofluorescent ring on fundus autofluorescence in ABCA4.

Abalem MF, Qian CX, Branham K, Schlegel D, Fahim AT, Khan NW, Heckenlively JR, Jayasundera KT.

Ophthalmic Genet. 2018 Jan-Feb;39(1):87-91. doi: 10.1080/13816810.2017.1335330. Epub 2017 Jul 20.

7.

Reliability of kinetic visual field testing in children with mutation-proven retinal dystrophies: Implications for therapeutic clinical trials.

Dedania VS, Liu JY, Schlegel D, Andrews CA, Branham K, Khan NW, Musch DC, Heckenlively JR, Jayasundera KT.

Ophthalmic Genet. 2018 Jan-Feb;39(1):22-28. doi: 10.1080/13816810.2017.1329447. Epub 2017 Jul 13.

8.

Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes.

Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT.

BMC Ophthalmol. 2016 Jul 29;16(1):129. No abstract available.

9.

Fungal Endophthalmitis Associated With DSAEK and Thermal Sclerostomy.

Wang SY, Ghodasra DH, Amin SR, Mian SI, Jayasundera KT.

Ophthalmic Surg Lasers Imaging Retina. 2016 Jul 1;47(7):691-3. doi: 10.3928/23258160-20160707-15.

PMID:
27434905
10.

Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.

Ghodasra DH, Fante R, Gardner TW, Langue M, Niziol LM, Besirli C, Cohen SR, Dedania VS, Demirci H, Jain N, Jayasundera KT, Johnson MW, Kalyani PS, Rao RC, Zacks DN, Sundstrom JM.

Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3017-23. doi: 10.1167/iovs.15-18721.

11.

Worldwide Argus II implantation: recommendations to optimize patient outcomes.

Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT.

BMC Ophthalmol. 2016 May 6;16:52. doi: 10.1186/s12886-016-0225-1. Review. Erratum in: BMC Ophthalmol. 2016;16(1):129.

12.

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis JL, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2016 Apr;164:29-36. doi: 10.1016/j.ajo.2015.12.028. Epub 2015 Dec 31.

13.

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9. doi: 10.1016/j.ajo.2015.09.017. Epub 2015 Sep 18.

14.
15.

Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE.

Ophthalmology. 2015 Oct;122(10):1967-75. doi: 10.1016/j.ophtha.2015.06.042. Epub 2015 Aug 20.

16.

PATHOGENESIS OF PERSISTENT PLACOID MACULOPATHY: A Multimodal Imaging Analysis.

Nika M, Kalyani PS, Jayasundera KT, Comer GM.

Retina. 2015 Aug;35(8):1531-9. doi: 10.1097/IAE.0000000000000496.

PMID:
25741814
17.

Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium.

Thompson DA, Ali RR, Banin E, Branham KE, Flannery JG, Gamm DM, Hauswirth WW, Heckenlively JR, Iannaccone A, Jayasundera KT, Khan NW, Molday RS, Pennesi ME, Reh TA, Weleber RG, Zacks DN; Monaciano Consortium.

Invest Ophthalmol Vis Sci. 2015 Feb 9;56(2):918-31. doi: 10.1167/iovs.14-16049. Review.

18.

The ophthalmic experience: unanticipated primary findings in the era of next generation sequencing.

Huang JT, Heckenlively JR, Jayasundera KT, Branham KE.

J Genet Couns. 2014 Aug;23(4):588-93. doi: 10.1007/s10897-013-9679-y. Epub 2014 Jan 8.

19.

Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease.

Branham K, Othman M, Brumm M, Karoukis AJ, Atmaca-Sonmez P, Yashar BM, Schwartz SB, Stover NB, Trzupek K, Wheaton D, Jennings B, Ciccarelli ML, Jayasundera KT, Lewis RA, Birch D, Bennett J, Sieving PA, Andreasson S, Duncan JL, Fishman GA, Iannaccone A, Weleber RG, Jacobson SG, Heckenlively JR, Swaroop A.

Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8232-7. doi: 10.1167/iovs.12-11025.

Supplemental Content

Loading ...
Support Center